10/9 science / biotechnologies news stories aggregated by FeedZilla.com

Please add updates@feedmyinbox.com to your address book to make sure you receive these messages in the future. science / biotechnologies news stories aggregated by FeedZilla.com Report ranks Colorado as average on health-system performance (source: Biz Journal) October 8, 2009 at 3:47 am A state-by-state assessment of health care ranks Colorado slightly better than average among the states, giving it a high rating on healthy living but low scores on access to care and the "equity" of its system. (source: Biz Journal) - RSS widgets and RSS feeds on Feedzilla.com Phadia Inc.: Celiac Disease Is a Silent Killer-Phadia to Launch Two New, Technologically-Advanced Diagnostic Tests (source: Market Wire) October 8, 2009 at 3:47 am UPPSALA, SWEDEN (MARKET WIRE) Phadia Inc., worldwide leaders in the development, manufacturing and marketing of complete blood test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases, today announced the launch of... (source: Market Wire) - RSS news feeds and Widgets on Feedzilla.com GPC Biotech AG: GPC Biotech Provides Update on Merger (source: Market Wire) October 8, 2009 at 3:47 am MARTINSRIED, GERMANY and PRINCETON, NJ (MARKET WIRE) GPC Biotech AG (FRANKFURT: GPC) (XETRA: GPC) today reported that its planned merger, under which the Company will combine its business with Agennix Incorporated, a privately held biotechnology company l... (source: Market Wire) - RSS and News widget on Feedzilla.com Chinese Food and Drug Administration Approves Gabexate Mesylate as Pharmaceutical Raw Material (source: prnewswire.com) October 8, 2009 at 1:00 am NANTONG CITY, China, Oct. 8 /PRNewswire-Asia-FirstCall/ -- Sinobiopharma, Inc. (OTC Bulletin Board: SNBP) ("Sinobiopharma") (the "Company") is pleased to announce that the Company received a certificate for the use of Gabexate mesylate as a pharmaceutical... (source: prnewswire.com) - RSS and News widget on Feedzilla.com Omeros Prices Initial Public Offering of Common Stock at $10.00 Per Share (source: prnewswire.com) October 7, 2009 at 11:54 pm SEATTLE, Wash., Oct. 7 /PRNewswire-FirstCall/ -- Omeros Corporation today announced the pricing of its initial public offering of 6.82 million shares of its common stock at a price of $10.00 per share. The underwriters have the option to purchase up to an ... (source: prnewswire.com) - RSS news feeds and Widgets on Feedzilla.com Canadian researchers decode DNA of breast cancer tumor (source: Biz Journal) October 7, 2009 at 7:07 pm A team of Canadian researchers has decoded the genetic structure of metastatic lobular breast cancer - a major breakthough that could lead to the development of new breast cancer treatments and therapies. (source: Biz Journal) - RSS and News widget on Feedzilla.com   This email was sent to 4ndr1fm@gmail.com.  Manage Your Account Don't want to receive this feed any longer? Unsubscribe here.